These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15476560)

  • 1. Evolutionary relationships of Aurora kinases: implications for model organism studies and the development of anti-cancer drugs.
    Brown JR; Koretke KK; Birkeland ML; Sanseau P; Patrick DR
    BMC Evol Biol; 2004 Oct; 4():39. PubMed ID: 15476560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora kinases.
    Bolanos-Garcia VM
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1572-7. PubMed ID: 15896667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora kinases: new targets for cancer therapy.
    Carvajal RD; Tse A; Schwartz GK
    Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating Aurora B as an anti-cancer drug target.
    Girdler F; Gascoigne KE; Eyers PA; Hartmuth S; Crafter C; Foote KM; Keen NJ; Taylor SS
    J Cell Sci; 2006 Sep; 119(Pt 17):3664-75. PubMed ID: 16912073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinases as anticancer drug targets.
    Gautschi O; Heighway J; Mack PC; Purnell PR; Lara PN; Gandara DR
    Clin Cancer Res; 2008 Mar; 14(6):1639-48. PubMed ID: 18347165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of Aurora kinase inhibitors in cancer.
    Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora kinase inhibitors as anti-cancer therapy.
    Lok W; Klein RQ; Saif MW
    Anticancer Drugs; 2010 Apr; 21(4):339-50. PubMed ID: 20016367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora A and B kinases as targets for cancer: will they be selective for tumors?
    Matthews N; Visintin C; Hartzoulakis B; Jarvis A; Selwood DL
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):109-20. PubMed ID: 16375648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora kinase inhibitors: a new class of targeted drugs in cancer.
    Gautschi O; Mack PC; Davies AM; Lara PN; Gandara DR
    Clin Lung Cancer; 2006 Sep; 8(2):93-8. PubMed ID: 17026809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.
    Aliagas-Martin I; Burdick D; Corson L; Dotson J; Drummond J; Fields C; Huang OW; Hunsaker T; Kleinheinz T; Krueger E; Liang J; Moffat J; Phillips G; Pulk R; Rawson TE; Ultsch M; Walker L; Wiesmann C; Zhang B; Zhu BY; Cochran AG
    J Med Chem; 2009 May; 52(10):3300-7. PubMed ID: 19402633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinases as an anti-cancer target.
    Ikezoe T
    Cancer Lett; 2008 Apr; 262(1):1-9. PubMed ID: 18294763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora A: target invalidated?
    Cochran AG
    Chem Biol; 2008 Jun; 15(6):525-6. PubMed ID: 18559262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Aurora B activation by INCENP and inhibition by hesperadin.
    Sessa F; Mapelli M; Ciferri C; Tarricone C; Areces LB; Schneider TR; Stukenberg PT; Musacchio A
    Mol Cell; 2005 Apr; 18(3):379-91. PubMed ID: 15866179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with aurora kinase inhibitors: a review.
    Boss DS; Beijnen JH; Schellens JH
    Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
    Arbitrario JP; Belmont BJ; Evanchik MJ; Flanagan WM; Fucini RV; Hansen SK; Harris SO; Hashash A; Hoch U; Hogan JN; Howlett AR; Jacobs JW; Lam JW; Ritchie SC; Romanowski MJ; Silverman JA; Stockett DE; Teague JN; Zimmerman KM; Taverna P
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):707-17. PubMed ID: 19649632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of selective aminothiazole aurora kinase inhibitors.
    Andersen CB; Wan Y; Chang JW; Riggs B; Lee C; Liu Y; Sessa F; Villa F; Kwiatkowski N; Suzuki M; Nallan L; Heald R; Musacchio A; Gray NS
    ACS Chem Biol; 2008 Mar; 3(3):180-92. PubMed ID: 18307303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora kinases as targets for cancer therapy.
    Mountzios G; Terpos E; Dimopoulos MA
    Cancer Treat Rev; 2008 Apr; 34(2):175-82. PubMed ID: 18023292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells.
    Sun L; Li D; Dong X; Yu H; Dong JT; Zhang C; Lu X; Zhou J
    Biochem Pharmacol; 2008 Mar; 75(5):1027-34. PubMed ID: 18163976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase inhibitors.
    Kitzen JJ; de Jonge MJ; Verweij J
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):99-110. PubMed ID: 19369091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.